Similarly, the number of tumor-infiltrating CD4+, CD8+, and NK (natural killer) cells able to produce IFN-γ was significantly higher in mice treated with CM1315 (Figure 5E), suggesting that Treg inhibition improved the antitumor immune response. This evidence concerns the gene CD4 and neoplasm.